Imagenes de peptido+similar+al+glucagon+tipo+1, fotos de stock y vectores

Se encuentran disponibles +52797 fotos, vectores e ilustraciones de stock libres de regalías sobre

Busquedas relacionadas:
Inyector de pluma de liraglutida con aguja para tratar la diabetes tipo 2 photo
Dos bolígrafos dosificadores de un fármaco ficticio de semaglutida (GLP-1) en una báscula frente a una mancuerna. Concepto de formas alternativas de perder peso. photo
Pluma de inyección automática de semaglutida photo
GLP-1 related drugs newspaper headlines with hand and magnifying glass photo
Two dosing pens of a fictitious semaglutide drug (GLP-1) on a scale facing a dumbbell. Concept for alternative ways to loose weight. photo
Pluma autoinyectora de semaglutida aislada photo
Concepto de formas alternativas de perder peso. Dos paquetes (diseño ficticio) de plumas dosificadoras de un medicamento ficticio de semaglutida utilizado para la pérdida de peso. En la parte trasera una mancuerna para hacer ejercicio. photo
Manejo de la diabetes mejorado con IA: terapia holográfica GLP-1 y análisis predictivo de la salud, molécula de péptido similar al glucagón 1 (GLP1, 7-36) El péptido-1 similar al glucagón y la pérdida de peso photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule, a potent antihyperglycemic hormone. A neuropeptide and an incretin, chemical structure. treatment of diabetes, Molecular surface, 3d render photo
El receptor del péptido-1 (GLP-1) similar al glucagón, inactivado y rodeado por un agonista (semaglutida, rojo) y proteínas G photo
Plumas inyectables de semaglutida con teléfono móvil photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor has a strong effect on the management of type 2 diabetes mellitus photo
El receptor del péptido-1 (GLP-1) similar al glucagón, se activó con un agonista (semaglutida) y proteínas G photo
El receptor del péptido-1 (GLP-1) similar al glucagón, forma inactiva (izquierda) y complejo activo con un agonista (semaglutida) y proteínas G photo
Pluma de dosis de siete días de dulaglutida para el tratamiento de la diabetes tipo 2 sobre fondo blanco photo
El péptido semaglutido que activa el receptor del péptido-1 similar al glucagón (GLP-1) photo
Titulares de periódicos relacionados con GLP-1 y semaglutida, para el tratamiento de la diabetes y la pérdida de peso photo
Teléfono celular de mano con bolígrafo de semaglutida photo
Representación 3D de la molécula del péptido 1 similar al glucagón (GLP1, 7-36), una potente hormona antihiperglucémica. Un neuropéptido y una incretina, estructura química. tratamiento de la diabetes, Superficie molecular photo
Representación 3D de la molécula del péptido 1 similar al glucagón (GLP1, 7-36), una potente hormona antihiperglucémica. Un neuropéptido y una incretina, estructura química. tratamiento de la diabetes, Superficie molecular photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor and syringe for the management of type 2 diabetes mellitus, type 2 diabetes photo
Molécula del péptido similar al glucagón 1 (GLP1, 7-36), una potente hormona antihiperglucémica. Un neuropéptido y una estructura química incretina. tratamiento de la diabetes, superficie molecular, renderizado 3d photo
Molécula de medicamento para la diabetes alogliptina. dipeptidil peptidasa 4 (DPP-4) o clase de gliptina de medicamentos antidiabéticos. fármaco antidiabético en la clase de inhibidores de DPP-4, render 3d photo
Pluma inyectora de semaglutida sobre bloques de madera photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule, a potent antihyperglycemic hormone. A neuropeptide and an incretin, chemical structure. treatment of diabetes, Molecular surface, 3d render photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor and syringe for the management of type 2 diabetes mellitus, type 2 diabetes photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule, a potent antihyperglycemic hormone. A neuropeptide and an incretin, chemical structure. treatment of diabetes, Molecular surface, 3d render photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor has a strong effect on the management of type 2 diabetes mellitus photo
Semaglutide antidiabetic drug, illustration photo
A bottle of GLP-1 supplements on a yellow background. The bottle is full of capsules, and there are a few capsules scattered in front of it. photo
Molecular structure of Semaglutide, a glucagon-like peptide-1 receptor agonist used for diabetes and weight management. photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor has a strong effect on the management of type 2 diabetes mellitus. 3d rendering photo
Glucagon-like peptide-1. GLP-1 from blood vessel to pancreas, brain and stomach. photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor has a strong effect on the management of type 2 diabetes mellitus. 3d rendering photo
Glucagonlike peptide 1 GLP1 736 molecule The glucagon like peptide1 receptor has a strong effect on the management of type 2 diabetes mellitus 3d rendering photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor has a strong effect on the management of type 2 diabetes mellitus. 3d rendering photo
leukotriene receptor antagonists play in lung treatment photo
Tirzepatide Rolling Vial (Closeup) photo
Glucagon-Like Peptide-1 Science Design Vector Illustration Diagram photo
3D Rendering of Glucagon-like Peptide 1 Molecule for Type 2 Diabetes Management photo
Liraglutide peptide drug molecule. Agonist of the glucagon-like peptide-1 receptor used in treatment of diabetes and obesity. photo
GLP1 Molecular Structure 3D Rendering of Glucagon-like Peptide-1 for Type 2 Diabetes Management photo
How does the use of glucagon-like peptide-1 receptor agonists impact cardiovascular risk in patients with diabetes? photo
Danuglipron (PF-06882961), a non-peptide agonist, activates the canonical G protein signaling activity only in the Glucagon-like peptide-1 (GLP-1) receptor with Trp33ECD photo
Liraglutide, a long-acting glucagon-like peptide-1 receptor agon photo
Glucagon-like Peptide-1 Molecular Structure 3D Rendering for Diabetes Management photo
Insulin Injection Pens on Conveyor Line that Transports Them during Production Process at Modern Pharmaceutical Factory. Medicinal Drug Production Plant. Weight Loss Medication Manufacturing. photo
Glp-1 glucagon like peptide-1, incretin mimetics, diabetes treatment drug efficacy, islet cell, beta cell, insulin sensitivity, semaglutide photo
3D Isometric Flat Conceptual Illustration of Glucagon-like Peptide-1, Digestive Hormones photo
Structural model of semaglutide, a glucagon-like peptide-1 receptor agonist used for treating type 2 diabetes. photo
A high-resolution microscopic image of a molecule of semaglutide, a glucagon-like peptide-1 receptor agonist. photo
A close-up image featuring a syringe filled with semaglutide solution, surrounded by tiny droplets of water. photo
Semaglutide molecule floating in a sea of glowing spheres that resemble its binding site on the glucagon-like peptide-1 receptor. photo
A microscopic view of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. photo
GLP-1. Glucagon-like peptide-1 photo
A high-resolution microscopic image of a molecule of semaglutide, which is an agonist for the human glucagon-like peptide-1 (GLP-1) receptor. photo
Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor and syringe for the management of type 2 diabetes mellitus, type 2 diabetes photo
Glucagon-like peptide-1. Weight loss therapy photo
Glucagon-like peptide-1. GLP-1 from blood vessel to pancreas, brain and stomach. relationship between Satiety, Appetite hormones, Insulin, Glucagon, Gastric motility and emptying. Vector Isometric Flat illustration. clipart
Prague,Czech republic-June 28 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 28 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 28 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 28 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 28 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Prague,Czech republic-June 27 2024: VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection clipart
Siguiente >